Wells Fargo & Company Lowers Danaher (NYSE:DHR) Price Target to $240.00

Danaher (NYSE:DHR) had its price target decreased by research analysts at Wells Fargo & Company from $280.00 to $240.00 in a report released on Thursday,Benzinga reports. The brokerage currently has an “equal weight” rating on the conglomerate’s stock. Wells Fargo & Company‘s price target would suggest a potential upside of 7.84% from the company’s previous close.

Other equities research analysts also recently issued research reports about the stock. Stephens restated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective on the stock. UBS Group decreased their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. Raymond James cut their price target on Danaher from $300.00 to $275.00 and set an “outperform” rating for the company in a report on Tuesday, January 21st. Finally, Royal Bank of Canada decreased their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Performance

Shares of DHR opened at $222.56 on Thursday. The company has a market capitalization of $160.75 billion, a PE ratio of 42.15, a price-to-earnings-growth ratio of 4.22 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher has a one year low of $221.34 and a one year high of $281.70. The company’s fifty day moving average price is $235.66 and its 200 day moving average price is $253.24.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.72% and a net margin of 16.33%. During the same period last year, the firm earned $2.09 EPS. As a group, analysts expect that Danaher will post 8.15 earnings per share for the current year.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Danaher

Several large investors have recently bought and sold shares of the business. Coronation Fund Managers Ltd. lifted its stake in shares of Danaher by 29.9% in the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after purchasing an additional 1,470 shares during the period. Quarry LP increased its holdings in Danaher by 250.6% in the second quarter. Quarry LP now owns 298 shares of the conglomerate’s stock valued at $74,000 after purchasing an additional 213 shares during the last quarter. Cetera Investment Advisers lifted its stake in Danaher by 6.5% in the second quarter. Cetera Investment Advisers now owns 130,209 shares of the conglomerate’s stock valued at $32,533,000 after buying an additional 7,986 shares during the period. Sanctuary Advisors LLC bought a new position in Danaher during the second quarter worth about $19,512,000. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of Danaher by 21.4% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 45,434 shares of the conglomerate’s stock worth $11,352,000 after buying an additional 8,006 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.